Literature DB >> 2110898

Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s.

M H Nissen1, P Roepstorff, L Thim, B Dunbar, J E Fothergill.   

Abstract

We have now demonstrated that activated complement component C1s cleaves beta 2-microglobulin at the position identical to that at which beta 2-microglobulin is cleaved in serum of patients suffering from lung cancer. The main cleavage is in the disulphide loop C-terminal to Lys-58, generating a modified form of beta 2-microglobulin with a two-chain structure. The C-terminal Lys-58 in the A chain is highly susceptible to removal by a carboxypeptidase-B-like activity causing the formation of des-Lys58-beta 2-microglobulin. This is the first demonstration of a noncomplement protein substrate for the proteolytic activity of C1s. The C1s-induced cleavage of beta 2-microglobulin can be inhibited in the presence of C1 esterase inhibitor, demonstrating a regulatory function of C1 esterase inhibitor in the C1s-induced cleavage of beta 2-microglobulin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110898     DOI: 10.1111/j.1432-1033.1990.tb15505.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Topological investigation of amyloid fibrils obtained from beta2-microglobulin.

Authors:  Maria Monti; Serena Principe; Sofia Giorgetti; Palma Mangione; Gianpaolo Merlini; Anne Clark; Vittorio Bellotti; Angela Amoresano; Piero Pucci
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

2.  Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.

Authors:  Sofia Giorgetti; Monica Stoppini; Glenys A Tennent; Annalisa Relini; Loredana Marchese; Sara Raimondi; Maria Monti; Sara Marini; Ole Østergaard; Niels H H Heegaard; Piero Pucci; Gennaro Esposito; Giampaolo Merlini; Vittorio Bellotti
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

3.  Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms.

Authors:  Olgica Trenchevska; Elena Kamcheva; Dobrin Nedelkov
Journal:  J Proteome Res       Date:  2010-09-23       Impact factor: 4.466

4.  Rheumatoid factors from patients with rheumatoid arthritis react with Des-Lys58-beta 2m, modified beta 2-microglobulin.

Authors:  R C Williams; M H Nissen; C C Malone
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.

Authors:  Lorraine R Washburn; Dan Zekzer; Shoshana Eitan; Yuxin Lu; Hoa Dang; Blake Middleton; Christopher J Evans; Jide Tian; Daniel L Kaufman
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

6.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

7.  Delineation of concentration ranges and longitudinal changes of human plasma protein variants.

Authors:  Olgica Trenchevska; David A Phillips; Randall W Nelson; Dobrin Nedelkov
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 8.  C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions.

Authors:  Jinhua Lu; Uday Kishore
Journal:  Front Immunol       Date:  2017-05-24       Impact factor: 7.561

9.  Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.

Authors:  P Riihilä; K Viiklepp; L Nissinen; M Farshchian; M Kallajoki; A Kivisaari; S Meri; J Peltonen; S Peltonen; V-M Kähäri
Journal:  Br J Dermatol       Date:  2019-07-28       Impact factor: 9.302

10.  Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.

Authors:  Maria Radanova; Vasil Vasilev; Galya Mihaylova; Mariya Kosturkova; Uday Kishore; Lubka Roumenina
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.